Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2022 Filed Mar 1, 2022 21:00 UTC |
Dold ChristopherChief Zoological Officer
|
SaleCommon Stock | 25,447 | $70.69 | $1,798,848.43 |
DisclosureSEC source: 0001209191-22-013961 · doc4.xml · nonDerivative · entry 2 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,320 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 19, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.31 to $71.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:00 UTC |
Dold ChristopherChief Zoological Officer
|
SaleCommon Stock | 21,370 | $70.03 | $1,496,541.10 |
DisclosureSEC source: 0001209191-22-013961 · doc4.xml · nonDerivative · entry 1 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,767 F1 · kind: The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 19, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $69.30 to $70.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 28, 2022 Filed Apr 18, 2022 20:00 UTC |
Finazzo Christopher L.Chief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 19,215 | $0.00 Strike: $69.39 | $0.00 |
DisclosureSEC source: 0001209191-22-024616 · doc4.xml · derivative · entry 2 Finazzo Christopher L. · CIK 0001801406 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,215 Underlying: Common Stock · 19,215 shares Expires 2032-02-28 F2 · derivative.exercise_date: The option becomes exercisable in three substantially equal annual installments beginning February 28, 2023. Read SEC document |
| February 28, 2022 Filed Apr 18, 2022 20:00 UTC |
Finazzo Christopher L.Chief Commercial Officer
|
GrantCommon Stock | 23,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-024616 · doc4.xml · nonDerivative · entry 1 Finazzo Christopher L. · CIK 0001801406 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,398 F1 · shares: Represents restricted stock units issued pursuant to the Issuer's 2017 Omnibus Incentive Plan, which vests over three years, with one third (1/3) vesting on each of the each of the first three anniversaries of the date of grant. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:00 UTC |
Yarris ChristopherChief Accounting Officer
|
Tax withholdingCommon Stock | 248 | $70.02 | $17,364.96 |
DisclosureSEC source: 0001209191-22-013519 · doc4.xml · nonDerivative · entry 2 Yarris Christopher · CIK 0001855568 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,491 F2 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:00 UTC |
Yarris ChristopherChief Accounting Officer
|
GrantCommon Stock | 869 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013519 · doc4.xml · nonDerivative · entry 1 Yarris Christopher · CIK 0001855568 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,739 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:01 UTC |
Dold ChristopherChief Zoological Officer
|
Tax withholdingCommon Stock | 2,537 | $70.02 | $177,640.74 |
DisclosureSEC source: 0001209191-22-013523 · doc4.xml · nonDerivative · entry 3 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,137 F3 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:01 UTC |
Dold ChristopherChief Zoological Officer
|
GrantCommon Stock | 2,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013523 · doc4.xml · nonDerivative · entry 2 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,674 F2 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:01 UTC |
Dold ChristopherChief Zoological Officer
|
GrantCommon Stock | 7,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013523 · doc4.xml · nonDerivative · entry 1 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,130 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2019 Long Term Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:01 UTC |
Nadeau Sharon PChief Human Resources Officer
|
Tax withholdingCommon Stock | 2,762 | $70.02 | $193,395.24 |
DisclosureSEC source: 0001209191-22-013522 · doc4.xml · nonDerivative · entry 3 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,482 F3 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:01 UTC |
Nadeau Sharon PChief Human Resources Officer
|
GrantCommon Stock | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013522 · doc4.xml · nonDerivative · entry 2 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,244 F2 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:01 UTC |
Nadeau Sharon PChief Human Resources Officer
|
GrantCommon Stock | 8,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013522 · doc4.xml · nonDerivative · entry 1 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,780 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2019 Long Term Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:01 UTC |
Nadeau Sharon PChief Human Resources Officer
|
Tax withholdingCommon Stock | 2,762 | $70.02 | $193,395.24 |
DisclosureSEC source: 0001209191-22-013524 · doc4.xml · nonDerivative · entry 3 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,482 F3 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:01 UTC |
Nadeau Sharon PChief Human Resources Officer
|
GrantCommon Stock | 2,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013524 · doc4.xml · nonDerivative · entry 2 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,244 F2 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 16:01 UTC |
Nadeau Sharon PChief Human Resources Officer
|
GrantCommon Stock | 8,877 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013524 · doc4.xml · nonDerivative · entry 1 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,780 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2019 Long Term Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:01 UTC |
Gulacsy ElizabethSee Remarks
|
Tax withholdingCommon Stock | 3,620 | $70.02 | $253,472.40 |
DisclosureSEC source: 0001209191-22-013521 · doc4.xml · nonDerivative · entry 3 Gulacsy Elizabeth · CIK 0001517415 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,781 F3 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:01 UTC |
Gulacsy ElizabethSee Remarks
|
GrantCommon Stock | 3,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013521 · doc4.xml · nonDerivative · entry 2 Gulacsy Elizabeth · CIK 0001517415 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,401 F2 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:01 UTC |
Gulacsy ElizabethSee Remarks
|
GrantCommon Stock | 5,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013521 · doc4.xml · nonDerivative · entry 1 Gulacsy Elizabeth · CIK 0001517415 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,835 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2019 Long Term Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:00 UTC |
Swanson MarcChief Executive Officer
|
Tax withholdingCommon Stock | 6,168 | $70.02 | $431,883.36 |
DisclosureSEC source: 0001209191-22-013520 · doc4.xml · nonDerivative · entry 3 Swanson Marc · CIK 0001570328 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,631 F3 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:00 UTC |
Swanson MarcChief Executive Officer
|
GrantCommon Stock | 7,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013520 · doc4.xml · nonDerivative · entry 2 Swanson Marc · CIK 0001570328 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,799 F2 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:00 UTC |
Swanson MarcChief Executive Officer
|
GrantCommon Stock | 8,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013520 · doc4.xml · nonDerivative · entry 1 Swanson Marc · CIK 0001570328 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,755 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2019 Long Term Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:00 UTC |
Taylor George AnthonySee Remarks
|
Tax withholdingCommon Stock | 5,886 | $70.02 | $412,137.72 |
DisclosureSEC source: 0001209191-22-013518 · doc4.xml · nonDerivative · entry 3 Taylor George Anthony · CIK 0001570331 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,297 F3 · kind: Shares withheld by the Company for the payment of tax liability incident to the vesting of shares of restricted stock. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:00 UTC |
Taylor George AnthonySee Remarks
|
GrantCommon Stock | 3,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013518 · doc4.xml · nonDerivative · entry 2 Taylor George Anthony · CIK 0001570331 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,183 F2 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2021 Bonus Incentive Plan. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 21:00 UTC |
Taylor George AnthonySee Remarks
|
GrantCommon Stock | 11,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013518 · doc4.xml · nonDerivative · entry 1 Taylor George Anthony · CIK 0001570331 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,113 F1 · shares: Represents common stock of the Issuer acquired upon settlement of a performance-based restricted stock unit award previously granted to the Reporting Person related to the 2019 Long Term Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:00 UTC |
MOLONEY THOMAS EDirector
|
GrantCommon Stock | 1,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000115 · doc4.xml · nonDerivative · entry 1 MOLONEY THOMAS E · CIK 0001109101 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,478 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 16:00 UTC |
KOPPELMAN CHARLESDirector
|
GrantCommon Stock | 1,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000111 · doc4.xml · nonDerivative · entry 1 KOPPELMAN CHARLES · CIK 0001158938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,537 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:00 UTC |
Gray WilliamDirector
|
GrantCommon Stock | 1,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000112 · doc4.xml · nonDerivative · entry 1 Gray William · CIK 0001407133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,040 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 16:00 UTC |
BENSION RONALDDirector
|
GrantCommon Stock | 1,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000114 · doc4.xml · nonDerivative · entry 1 BENSION RONALD · CIK 0001242402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,892 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:00 UTC |
Schaefer KimberlyDirector
|
GrantCommon Stock | 1,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000116 · doc4.xml · nonDerivative · entry 1 Schaefer Kimberly · CIK 0001335887 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,542 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:00 UTC |
Hartnett TimothyDirector
|
GrantCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000117 · doc4.xml · nonDerivative · entry 1 Hartnett Timothy · CIK 0001833849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,312 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:00 UTC |
Maruyama YoshikazuDirector
|
GrantCommon Stock | 1,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000113 · doc4.xml · nonDerivative · entry 1 Maruyama Yoshikazu · CIK 0001710109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,931 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:00 UTC |
Narang Neha JoganiDirector
|
GrantCommon Stock | 992 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000118 · doc4.xml · nonDerivative · entry 1 Narang Neha Jogani · CIK 0001789425 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,347 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 02:32 UTC |
CHAMBERS JAMES P.Director
|
GrantCommon Stock, par value $0.01 | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-22-000061 · form411269002cha_01042022.xml · nonDerivative · entry 1 CHAMBERS JAMES P. · CIK 0001778860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,474 F1 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 02:35 UTC |
Hill Path Capital Partners S GP LLC10% owner
Hill Path Holdings LLC10% owner
HEP FUND LP10% owner
HM FUND LP10% owner
HE GP LLC10% owner
HM GP LLC10% owner
|
GrantCommon Stock | 1,903 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-22-000065 · form411269002b_01042022.xml · nonDerivative · entry 1 Hill Path Capital Partners Co-Investment S LP · CIK 0001710571 · 10% owner Hill Path Capital Partners S GP LLC · CIK 0001711306 · 10% owner Hill Path Holdings LLC · CIK 0001676388 · 10% owner HEP FUND LP · CIK 0001778825 · 10% owner HM FUND LP · CIK 0001778807 · 10% owner HE GP LLC · CIK 0001778844 · 10% owner HM GP LLC · CIK 0001778909 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Scott Ross Disclosed balance after: 49,101 F1 · security: This Form 4 is filed jointly by Hill Path Capital Partners LP ("Hill Path Capital"), Hill Path Co-Investment Partners LP ("Hill Path Co-Investment"), Hill Path Capital Partners-H LP ("Hill Path H"), Hill Path Capital Partners Co-Investment E LP ("Hill Path E"), Hill Path Capital Partners Co-Investment E2 LP ("Hill Path E2"), Hill Path Capital Partners Co-Investment S LP ("Hill Path S"), HEP Fund LP ("HEP Fund"), HM Fund LP ("HM Fund"), Hill Path Capital Partners GP LLC ("Hill Path GP"), Hill Path Capital Partners E GP LLC ("Hill Path E GP"), Hill Path Capital Partners S GP LLC ("Hill Path S GP"), HE GP LLC ("HE GP"), HM GP LLC ("HM GP"), Hill Path Investment Holdings LLC ("Hill Path Investment Holdings"), Hill Path Capital LP ("Hill Path"), Hill Path Holdings LLC ("Hill Path Holdings") and Scott Ross ("Mr. Ross," and collectively with the aforementioned entities, the "Reporting Persons"). F2 · security: To enable all of the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the second of two identical reports relating to the same transactions being filed with the Securities and Exchange Commission. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group along with HAT Fund LP and HAT Fund II LP, which do not beneficially own any shares of Common Stock, that collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Ross is also a director of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 02:34 UTC |
Hill Path Capital Partners LP10% owner
Hill Path Capital Partners-H LP10% owner
Hill Path Capital Partners GP LLC10% owner
Hill Path Capital Partners E GP LLC10% owner
Hill Path Investment Holdings LLC10% owner
Hill Path Capital LP10% owner
ROSS SCOTT IDirector · 10% owner
|
GrantCommon Stock | 1,903 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-22-000063 · form411269002a_01042022.xml · nonDerivative · entry 1 Hill Path Capital Partners LP · CIK 0001661914 · 10% owner Hill Path Capital Partners-H LP · CIK 0001661915 · 10% owner Hill Path Capital Co-Investment Partners LP · CIK 0001661913 · 10% owner Hill Path Capital Partners Co-Investment E LP · CIK 0001705700 · 10% owner Hill Path Capital Partners Co-Investment E2 LP · CIK 0001705698 · 10% owner Hill Path Capital Partners GP LLC · CIK 0001676386 · 10% owner Hill Path Capital Partners E GP LLC · CIK 0001705699 · 10% owner Hill Path Investment Holdings LLC · CIK 0001676389 · 10% owner Hill Path Capital LP · CIK 0001676292 · 10% owner ROSS SCOTT I · CIK 0001549220 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Scott Ross Disclosed balance after: 49,101 F1 · security: This Form 4 is filed jointly by Hill Path Capital Partners LP ("Hill Path Capital"), Hill Path Co-Investment Partners LP ("Hill Path Co-Investment"), Hill Path Capital Partners-H LP ("Hill Path H"), Hill Path Capital Partners Co-Investment E LP ("Hill Path E"), Hill Path Capital Partners Co-Investment E2 LP ("Hill Path E2"), Hill Path Capital Partners Co-Investment S LP ("Hill Path S"), HEP Fund LP ("HEP Fund"), HM Fund LP ("HM Fund"), Hill Path Capital Partners GP LLC ("Hill Path GP"), Hill Path Capital Partners E GP LLC ("Hill Path E GP"), Hill Path Capital Partners S GP LLC ("Hill Path S GP"), HE GP LLC ("HE GP"), HM GP LLC ("HM GP"), Hill Path Investment Holdings LLC ("Hill Path Investment Holdings"), Hill Path Capital LP ("Hill Path"), Hill Path Holdings LLC ("Hill Path Holdings") and Scott Ross ("Mr. Ross," and collectively with the aforementioned entities, the "Reporting Persons"). F2 · security: To enable the Reporting Persons to gain access to the Securities and Exchange Commission's electronic filing system (which only accepts a maximum of 10 joint filers per report), this report is the first of two identical reports relating to the same transactions being filed with the Securities and Exchange Commission. Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group along with HAT Fund LP and HAT Fund II LP, which do not beneficially own any shares of Common Stock, that collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Mr. Ross is also a director of the Issuer. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3 · shares: Granted under the Issuer's 2017 Omnibus Incentive Plan. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:00 UTC |
Nadeau Sharon PChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,858 | $0.00 Strike: $27.21 | $0.00 |
DisclosureSEC source: 0001209191-21-068294 · doc4.xml · derivative · entry 5 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Underlying: Common Stock · 3,858 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 7,717 shares, became exercisable in two equal annual installments beginning on February 28, 2021, which was the first anniversary of the date on which the option was granted. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:00 UTC |
Nadeau Sharon PChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,376 | $0.00 Strike: $31.00 | $0.00 |
DisclosureSEC source: 0001209191-21-068294 · doc4.xml · derivative · entry 4 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,688 Underlying: Common Stock · 5,376 shares Expires 2029-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing a right to purchase a total of 8,064 shares, became exercisable in three equal annual installments beginning on August 15, 2020, which was the first anniversary of the date on which the option was granted. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:00 UTC |
Nadeau Sharon PChief Human Resources Officer
|
SaleCommon Stock | 9,234 | $61.90 | $571,584.60 |
DisclosureSEC source: 0001209191-21-068294 · doc4.xml · nonDerivative · entry 3 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,903 Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:00 UTC |
Nadeau Sharon PChief Human Resources Officer
|
Exercise / conversionCommon Stock | 3,858 | $27.21 | $104,976.18 |
DisclosureSEC source: 0001209191-21-068294 · doc4.xml · nonDerivative · entry 2 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 16:00 UTC |
Nadeau Sharon PChief Human Resources Officer
|
Exercise / conversionCommon Stock | 5,376 | $31.00 | $166,656.00 |
DisclosureSEC source: 0001209191-21-068294 · doc4.xml · nonDerivative · entry 1 Nadeau Sharon P · CIK 0001332931 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:00 UTC |
Hartnett TimothyDirector
|
PurchaseCommon Stock | 2,500 | $65.00 | $162,500.00 |
DisclosureSEC source: 0001209191-21-066772 · doc4.xml · nonDerivative · entry 1 Hartnett Timothy · CIK 0001833849 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,601 F1 · kind: Open market purchase. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,837 | $0.00 Strike: $27.21 | $0.00 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · derivative · entry 11 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,675 Underlying: Common Stock · 1,837 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing a right to purchase a total of 1,837 shares, became exercisable in three equal annual installments beginning on February 28, 2021, which was the first anniversary of the date on which the option was granted. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,295 | $0.00 Strike: $25.70 | $0.00 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · derivative · entry 10 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,648 Underlying: Common Stock · 7,295 shares Expires 2029-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing a right to purchase a total of 7,295 shares, became exercisable in three equal annual installments beginning on March 14, 2020, which was the first anniversary of the date on which the option was granted. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,480 | $0.00 Strike: $14.17 | $0.00 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · derivative · entry 9 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,480 shares Expires 2026-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing a right to purchase a total of 5,480 shares, became exercisable in four equal annual installments beginning on July 1, 2017, which was the first anniversary of the date on which the option was granted. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,391 | $0.00 Strike: $18.17 | $0.00 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · derivative · entry 8 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,391 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a right to purchase a total of 6,391 shares, became exercisable in four equal annual installments beginning on March 1, 2017, which was the first anniversary of the date on which the option was granted. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,459 | $0.00 Strike: $18.96 | $0.00 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · derivative · entry 7 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,459 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 5,459 shares, became exercisable in four equal annual installments beginning on March 3, 2016, which was the first anniversary of the date on which the option was granted. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
SaleCommon Stock | 26,462 | $63.00 | $1,667,106.00 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · nonDerivative · entry 6 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,252 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.00 to $63.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionCommon Stock | 1,837 | $27.21 | $49,984.77 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · nonDerivative · entry 5 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionCommon Stock | 7,295 | $25.70 | $187,481.50 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · nonDerivative · entry 4 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 14:00 UTC |
Dold ChristopherChief Zoological Officer
|
Exercise / conversionCommon Stock | 5,480 | $14.17 | $77,651.60 |
DisclosureSEC source: 0001209191-21-065697 · doc4.xml · nonDerivative · entry 3 Dold Christopher · CIK 0001671261 · Chief Zoological Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.